this post was submitted on 20 Aug 2023
575 points (97.7% liked)
ADHD
9625 readers
3 users here now
A casual community for people with ADHD
Values:
Acceptance, Openness, Understanding, Equality, Reciprocity.
Rules:
- No abusive, derogatory, or offensive post/comments.
- No porn, gore, spam, or advertisements allowed.
- Do not request for donations.
- Do not link to other social media or paywalled content.
- Do not gatekeep or diagnose.
- Mark NSFW content accordingly.
- No racism, homophobia, sexism, ableism, or ageism.
- Respectful venting, including dealing with oppressive neurotypical culture, is okay.
- Discussing other neurological problems like autism, anxiety, ptsd, and brain injury are allowed.
- Discussions regarding medication are allowed as long as you are describing your own situation and not telling others what to do (only qualified medical practitioners can prescribe medication).
Encouraged:
- Funny memes.
- Welcoming and accepting attitudes.
- Questions on confusing situations.
- Seeking and sharing support.
- Engagement in our values.
Relevant Lemmy communities:
lemmy.world/c/adhd will happily promote other ND communities as long as said communities demonstrate that they share our values.
founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
You've perhaps conflated two opposing diagnostic approaches. The extant approach in most Western countries is to use the Diagnostic and Statistic Manual (DSM), which provides categorical guidelines for diagnosis of mental health disorders based on symptom clusters. Although not a contender or replacement for the DSM, a new approach that considers more factors has been developed by the US National Institute of Mental Health. This new approach is referred to as the Research Domain Criteria (RDoC) and it proposes basing diagnoses on both clinical observations AND objective neuroscientific methods. Part of the RDoC approach is to view disorders as reflecting multiple traits on a continuum (i.e. spectrum). It's hoped this newer approach can improve care outcomes for disorders where symptom presentation varies greatly between individuals (i.e., schizophrenia) or genders (i.e., ASD).